Limited Utility for Benzodiazepines in Chronic Pain Management: A Narrative Review
Open Access
- 6 May 2020
- journal article
- review article
- Published by Springer Nature in Advances in Therapy
- Vol. 37 (6) , 2604-2619
Abstract
Introduction Controversy and uncertainty exist about the use of benzodiazepine receptor agonists (BZRAs) in pain management. This article curates available research to determine the appropriate role of BZRAs in the course of pain management, and how prescribers might address these challenges. Methods A narrative review was performed to determine the appropriate role of BZRAs in pain management and to develop practice recommendations. Publications were identified by a search of PubMed, references of retrieved reports, guidelines, and the author’s personal files. Results BZRAs were found to have analgesic benefit for two pain conditions: burning mouth syndrome and stiff person syndrome. Absence of research, heterogeneity of trials, and small sample sizes precluded drawing conclusions about efficacy of BZRAs for the other 109 pain conditions explored. Data supports the use of BZRAs to treat co-occurring insomnia and anxiety disorders but only when alternatives are inadequate and only for short periods of time (2–4 weeks). The utility of BZRAs is limited by loss of efficacy that may be seen with continued use and adverse reactions including physiologic dependence which develops in 20–100% of those who take these agents for more than a month. Conclusions BZRAs are often used inappropriately in pain management. Their initiation and duration of use should be limited to a narrow range of conditions. When prescribed for 4 weeks or more, patients should be encouraged to discontinue them through a supported, slow tapering process that may take 12–18 months or longer.Keywords
This publication has 158 references indexed in Scilit:
- Hypnotics' association with mortality or cancer: a matched cohort studyBMJ Open, 2012
- Inhibition of Recombinant L-Type Voltage-Gated Calcium Channels by Positive Allosteric Modulators of GABAA ReceptorsThe Journal of Pharmacology and Experimental Therapeutics, 2011
- Systematic review of modulators of benzodiazepine receptors in irritable bowel syndrome: Is there hope?World Journal of Gastroenterology, 2011
- Prevalence of sleep disturbance in patients with low back painEuropean Spine Journal, 2010
- Spinal translocator protein (TSPO) modulates pain behavior in rats with CFA-induced monoarthritisBrain Research, 2009
- Potentially inappropriate medication prescribing in outpatient practices: Prevalence and patient characteristics based on electronic health recordsThe American Journal of Geriatric Pharmacotherapy, 2009
- Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: A systematic reviewProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2009
- Central Sensitivity Syndromes: A New Paradigm and Group Nosology for Fibromyalgia and Overlapping Conditions, and the Related Issue of Disease versus IllnessSeminars in Arthritis and Rheumatism, 2008
- An internet survey of 2,596 people with fibromyalgiaBMC Musculoskeletal Disorders, 2007
- Physicians’ Perspectives on Prescribing Benzodiazepines for Older Adults: A Qualitative StudyJournal of General Internal Medicine, 2007